Czech Ammunition Producer Plans €3 Billion Amsterdam IPO in What Could Be Defense Industry's Largest Listing

Europe's Defense Boom Faces Its First Big Test as Czech Arms Maker Eyes Record IPO

When Czechoslovak Group announced plans Wednesday for what could become the largest defense IPO on record, the Prague-based ammunition and armored vehicle manufacturer crystallized a remarkable transformation: an industry once shunned by investors for ethical concerns has become Europe's hottest investment theme. But the €3 billion offering also poses an uncomfortable question—whether the market is pricing in a supercycle or a bubble.

The Ammunition Advantage in a Capacity-Starved Market

CSG's timing exploits a brutal reality of European rearmament: platforms are useless without sustained munitions supply. The company reported €4.49 billion in revenue through September 2025, up 82% year-over-year, with roughly 25% derived from Ukraine. Its €14 billion order backlog and 27.6% EBITDA margin reflect what one analyst called the "bottleneck category" dynamic—ammo producers can compound faster than prime contractors because procurement cycles are shorter and replenishment is recurring.

Owner Michal Strnad, 33, has built this position through aggressive acquisition, including the $2.2 billion purchase of U.S. ammunition maker Kinetic Group in 2024. The strategy targets vertical integration in a market where European governments, burned by dependence on U.S. supply chains, are desperate for sovereign capacity. CSG's cornerstone commitments—€900 million from Artisan Partners, BlackRock, and a Qatar Investment Authority subsidiary—effectively pre-sold a large portion of the €750 million primary offering before public marketing even began.

The Valuation Dilemma: Scarcity Rents or Structural Margins?

Yet the deal's reported €30 billion valuation reveals the central tension. At approximately 27 times EV/EBITDA, CSG would trade at nearly double the multiples of BAE Systems or Leonardo . This premium demands conviction that current margins aren't "peak-war" economics—scarcity rents and rush orders—but structural advantages from scale and integration.

The €900 million cornerstone book, while impressive, raises its own question: if institutional demand is so robust, why not increase the primary raise or structure a larger greenshoe? The likely answer involves threading a political needle—avoiding the appearance of aggressive founder cash-out while enabling a headline-grabbing transaction. That calculus suggests sensitivity to ESG optics even as European investors abandon old taboos. Norway's sovereign wealth fund, which maintained a 21-year defense investment prohibition, now eyes the sector.

What the Prospectus Won't Advertise

The real underwriting challenge lies in variables the marketing won't emphasize. First, customer concentration and contract quality—how much of that €14 billion backlog represents firm orders versus framework agreements with option value but no revenue guarantee? Second, working capital intensity from ammunition inventories and defense receivables, particularly as CSG integrates multiple acquisitions. Third, pass-through clauses for energy and materials costs, critical for protecting margins as wartime scarcity premiums normalize.

The strategic risk isn't a peace deal—Europe still needs stockpile replenishment regardless of Ukraine's outcome. Rather, it's multiple compression when investors rotate away from "defense momentum." The STOXX Europe Aerospace & Defense Index hit a 52-week high January 13, up 11% year-to-date, suggesting the easy re-rating occurred in 2022-2025. From here, returns depend on delivery against capacity plans, not narrative.

CSG also inherits U.S. regulatory exposure through Kinetic, which sparked Washington debate about foreign ownership of domestic ammunition capacity. Export controls and "trusted supplier" status are fragile competitive moats in an industry where geopolitics can rewrite the rules overnight.

The Investor's Calculus

For professional buyers, the edge comes not from embracing the macro "defense supercycle" story—everyone already owns that—but from forensic analysis of net debt, working capital turns, and whether pricing power persists once European capacity additions come online. Multiple analysts warned that aggressive valuations leave little room for execution stumbles or demand normalization.

The cornerstone structure signals institutional confidence, but also reveals something else: this is a business good enough to own, potentially at a price too high to buy. CSG represents exactly what 2026's market craves—scaled, scarce-capacity manufacturing tied to European sovereignty. Whether it represents value depends entirely on terms the market hasn't yet seen.

NOT INVESTMENT ADVICE